GlassScriptPhysician profile
Ashley Lavender
NPI 1205399623
$1,353.25
in general payments reported to CMS, 2019-2025
15 companies · $512 in 2025
The $512 reported for 2025 was more than what 86% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $144 · 2022: $195 · 2023: $175 · 2024: $328 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $926 · Education: $87.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $926.23 |
| Education | $87.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $272.42 | 2021-2023 | Kyprolis |
| Janssen Biotech, INC. | $200.44 | 2022-2025 | Rybrevant, Tecvayli, Talvey |
| Genentech USA, INC. | $182.60 | 2024-2025 | Polivy, Tecentriq |
| Csl Behring | $128.73 | 2024-2025 | Hizentra |
| Takeda Pharmaceuticals U.S.A., INC. | $116.20 | 2023-2025 | Fruzaqla, Alunbrig |
| Abbvie INC. | $88.95 | 2023-2025 | |
| Ipsen Biopharmaceuticals, INC | $87.99 | 2025 | |
| Pharmacyclics LLC, An Abbvie Company | $51.25 | 2023 | Imbruvica, Epkinly |
| Puma Biotechnology, INC. | $50.14 | 2023 | Nerlynx |
| Hologic Sales and Service, LLC | $36.39 | 2022 | |
| Servier Pharmaceuticals LLC | $34.04 | 2024 | |
| Inari Medical, INC. | $32.14 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Recordati_rare_diseases_inc. | $31.00 | 2025 | Sylvant |
| Janssen Scientific Affairs, LLC | $25.70 | 2024 | Rybrevant |
| Taiho Oncology, INC. | $15.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Lavender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.